Skip to content

Clinical study of the use of micronized Acellular Dermal Matrix (mADM) for the treatment of atrophic acne scars

Clinical study of the use of micronized Acellular Dermal Matrix (mADM) for the treatment of atrophic acne scars

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061288
Enrollment
Unknown
Registered
2022-06-19
Start date
2021-06-10
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophic acne scar

Interventions

Experimental group:mADM combined with PRP

Sponsors

Dermatology Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for acne depressed scar; 2. Boxcar scar, Rolling scar; 3. Facial (range: below the hairline, above the lower edge of the mandible, and in front of the ears) acne has been cured, the atrophic acne scar is stable for about 6 months; 4. The age is between 18-50 years old; Men and women are not limited.

Exclusion criteria

Exclusion criteria: 1. Receive other treatments for acne pitting scars within 3 months before treatment; 2. Persons with previous mental disorders, severe psychological disorders, and other important organ diseases who cannot be followed up for a long time; 3. Women in preparation for pregnancy, pregnancy, and lactation; 4. Patients allergic to lidocaine; 5. Patients with allergies such as collagen.

Design outcomes

Primary

MeasureTime frame
Acne Scar Assessment Scale (ASAS);ECCA grading scale;Self-satisfaction survey;

Countries

China

Contacts

Public ContactWang Chunmei

Dermatology Hospital of Southern Medical University

1944134044@qq.com+86 13717341078

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026